Surmodics Buyback Yield
Delisted
Buyback Yield of Surmodics (SRDX) as of Oct 11, 2026.
Get this data via API
Financial Data API
Buyback Yield
0.00
Last updated:
Buyback Yield of Surmodics is 2024 0.00 . Buyback Yield of Surmodics was 2023 0.15 % . It decreases by % lower compared to the previous year.
The Surmodics Buyback Yield history
3 Years
10 Years
25 Years
Max
Buyback Yield
Date
Buyback Yield
Jan 1, 2017
1.12 USD
Jan 1, 2018
0.74 USD
Jan 1, 2019
0.44 USD
Jan 1, 2020
0.41 USD
Jan 1, 2021
0.45 USD
Jan 1, 2022
0.18 USD
Jan 1, 2023
0.15 USD
Jan 1, 2024
0.00 USD
| YEAR | Buyback Yield | YoY |
|---|---|---|
| 0.00 | -100.00% | |
| 0.15 % | -18.11% | |
| 0.18 % | -59.25% | |
| 0.45 % | +8.56% | |
| 0.41 % | -5.73% | |
| 0.44 % | -41.01% | |
| 0.74 % | -33.55% | |
| 1.12 % | +1,667.53% | |
| 0.06 % | -98.14% | |
| 3.39 % | +52.50% | |
| 2.22 % | — |
Access this data via the Eulerpool API
Surmodics Stock analysis
What does Surmodics do? Surmodics Inc is an American company specializing in medical technology, based in Eden Prairie, Minnesota. They focus on developing and commercializing technologies to improve disease diagnosis and treatment. The company offers a wide range of medical devices and solutions for various medical applications, including cardiology, radiology, oncology, ophthalmology, and pharmaceutical development. Surmodics operates in three main business areas: medical devices, hollow fiber technology, and bioactive coatings. Their products are designed to meet the specific needs of customers and medical applications. Surmodics has a strong global presence and has expanded through strategic acquisitions in recent years, particularly in the pharmaceutical development and hollow fiber technology sectors. Surmodics is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Surmodics stock
On Eulerpool you can find the complete historical development of Buyback Yield Surmodics since 2006 – with annual values, charts, and detailed analysis.
Buyback yield measures the percentage of market cap returned to shareholders through share repurchases. It complements dividend yield in assessing total shareholder returns.
To evaluate Buyback Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Buyback Yield.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Buyback Yield's Surmodics with sector peers and the industry average to assess whether it is attractive.
Access this data via the Eulerpool API
Valuation — Surmodics
All Key Metrics — Surmodics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth